| Citation: |
XING Laijing, LIU Yancun, WANG Yu, YANG Qiaofang. A comparative study of two Nomograph risk factor predictive models of chronic heart failure with renal insufficiency[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 91-96, 101. DOI: 10.7619/jcmp.20230672
|
To construct two Nomograph risk factor predictive models for chronic heart failure patients with renal insufficiency based on Lasso-Logistic regression analysis and compare their efficacy.
The clinical data of 996 patients with chronic heart failure were collected. These patients were randomly divided into modeling group(698 cases) and verification group(298 cases) in a ratio of 7∶3. Lasso regression was used to screen variables, multivariate Logistic regression was used to screen independent risk factors for variables with statistical significance, and two models were compared to the evaluate their clinical effectiveness.
Of 698 patients in the modeling group, 148(21.20%) were complicated with renal insufficiency. Multivariate Logistic regression results of model 1 showed that hemoglobin, creatinine, uric acid, age, valvular heart disease, and presence or absence of complication were independent risk influencing factors(P < 0.05). Multivariate Logistic regression results of model 2 showed that hemoglobin, creatinine, uric acid, and presence or absence of complication were independent influencing factors (P < 0.05). The area under the curve (AUC) of model 1 was 0.814, and Hosmer-Leishow test results showed that it did not deviate, and was perfectly matched (P=0.08), the calibration chart showed that the model has good consistency. The AUC of model 2 was 0.806. The results of Hosmer-Lemeshow showed that the model was deviated from the perfect fit (P < 0.01), and the calibration chart showed that the consistency of the model was poor. The results of the validation group showed that the AUCs of model 1 and model 2 were 0.835, 0.824, respectively. Hosmer Lemeshow test showed that the models did not deviate from the perfect fit (P=0.12, 0.45), and the calibration curve also had good consistency.
The two Nomograph risk factors predictive models based on Lasso-Logistic regression have better ability in predicting the risk of chronic heart failure patients with renal insufficiency, but model 1 has better differentiation, consistency beween Hosmer-Lemeshow test results and calibration curve, stronger clinical applicability and higher net benefit, so model 1 is recommended for clinical application.
| [1] |
LAN T, LIAO Y H, ZHANG J, et al. Mortality and readmission rates after heart failure: a systematic review and meta-analysis[J]. Ther Clin Risk Manag, 2021, 17: 1307-1320. doi: 10.2147/TCRM.S340587
|
| [2] |
LIM Y M F, ONG S M, KOUDSTAAL S, et al. Trends for readmission and mortality after heart failure hospitalisation in Malaysia, 2007 to 2016[J]. Glob Heart, 2022, 17(1): 20. doi: 10.5334/gh.1108
|
| [3] |
EMMONS-BELL S, JOHNSON C, ROTH G. Prevalence, incidence and survival of heart failure: a systematic review[J]. Heart, 2022, 108(17): 1351-1360. doi: 10.1136/heartjnl-2021-320131
|
| [4] |
LÖFMAN I, SZUMMER K, DAHLSTRÖM U, et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction[J]. Eur J Heart Fail, 2017, 19(12): 1606-1614. doi: 10.1002/ejhf.821
|
| [5] |
中华人民共和国国务院. 中国防治慢性病中长期规划(2017—2025年)[J]. 中国实用乡村医生杂志, 2017, 24(11): 6-11. doi: 10.3969/j.issn.1672-7185.2017.11.002
|
| [6] |
郭艺芳. 2022年美国心力衰竭管理指南更新要点解读[J]. 中国全科医学, 2022, 25(17): 2051-2054. doi: 10.12114/j.issn.1007-9572.2022.0288
|
| [7] |
NELSON R G, GRAMS M E, BALLEW S H, et al. Development of risk prediction equations for incident chronic kidney disease[J]. JAMA, 2019, 322(21): 2104-2114. doi: 10.1001/jama.2019.17379
|
| [8] |
澈乐木格, 邓龙廉, 赵建全. 预测早发冠心病的发生风险: 临床列线图的开发和评估[J]. 实用临床医药杂志, 2022, 26(24): 51-56. doi: 10.7619/jcmp.20222458
|
| [9] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 慢性心力衰竭基层诊疗指南(实践版·2019)[J]. 中华全科医师杂志, 2019, 18(10): 948-956. doi: 10.3760/cma.j.issn.1671-7368.2019.10.009
|
| [10] |
TRIPOSKIADIS F, XANTHOPOULOS A, PARISSIS J, et al. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers[J]. Heart Fail Rev, 2022, 27(1): 337-344. doi: 10.1007/s10741-020-09987-z
|
| [11] |
CHA′ON U, TIPPAYAWAT P, SAE-UNG N, et al. High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand[J]. Sci Rep, 2022, 12(1): 18188. doi: 10.1038/s41598-022-22538-w
|
| [12] |
黄荔荔, 徐琴, 沈建宏, 等. 228例心力衰竭患者非计划再入院率调查及logistic预测模型建立研究[J]. 中国心血管病研究, 2022, 20(9): 811-816. doi: 10.3969/j.issn.1672-5301.2022.09.006
|
| [13] |
康元, 牛晓菁, 史秩菁, 等. 红细胞比容对老年女性心力衰竭患者3年不良结局事件的预测意义[J]. 中华老年心脑血管病杂志, 2022, 24(9): 908-911. doi: 10.3969/j.issn.1009-0126.2022.09.004
|
| [14] |
吴超, 赵雪燕, 袁晋青, 等. 心力衰竭患者NT-proANP、NT-proBNP和NT-proCNP与肾功能指标的相关性分析[J]. 南昌大学学报: 医学版, 2021, 61(2): 34-38, 67. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYB202102007.htm
|
| [15] |
徐玲玲, 周阳, 刘瑾, 等. 江苏省滨海县社区体检人群慢性肾功能不全的患病率及其相关因素调查[J]. 中华肾脏病杂志, 2022, 38(6): 520-527. doi: 10.3760/cma.j.cn441217-20211122-00072
|
| [16] |
孙磊, 李禄全, 杨晓慧. 基于决策曲线分析的临床预后重要影响因素研究[J]. 中国卫生统计, 2018, 35(6): 846-849. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201806011.htm
|
| [17] |
奚丽婧, 郭昭艳, 杨雪珂, 等. LASSO及其拓展方法在回归分析变量筛选中的应用[J]. 中华预防医学杂志, 2023, 57(1): 107-111. doi: 10.3760/cma.j.cn112150-20220117-00063
|
| [18] |
CHANG H J, LIN K R, CHANG J L, et al. Risk factors for chronic kidney disease in older adults with hyperlipidemia and/or cardiovascular diseases in Taipei city, Taiwan: a community-based cross-sectional analysis[J]. Int J Environ Res Public Health, 2020, 17(23): 8763. doi: 10.3390/ijerph17238763
|
| [19] |
何珊, 关晓楠, 马桂伶, 等. 青年与中老年心力衰竭患者的临床特点及预后研究[J]. 中国临床医生杂志, 2023, 51(1): 24-27. doi: 10.3969/j.issn.2095-8552.2023.01.008
|
| [20] |
何文静. 血管紧张素抑制剂对心力衰竭合并肾性贫血患者肌酐和血红蛋白的影响[J]. 心脑血管病防治, 2019, 19(2): 153-155, 173. doi: 10.3969/j.issn.1009-816x.2019.02.015
|
| [21] |
JANUS S E, HAJJARI J, CHAMI T, et al. Multi-variable biomarker approach in identifying incident heart failure in chronic kidney disease: results from the Chronic Renal Insufficiency Cohort study[J]. Eur J Heart Fail, 2022, 24(6): 988-995. doi: 10.1002/ejhf.2543
|
| [22] |
HOEVELMANN J, MAHFOUD F, LAUDER L, et al. Valvular heart disease in patients with chronic kidney disease[J]. Herz, 2021, 46(3): 228-233. doi: 10.1007/s00059-020-05011-0
|
| [23] |
TERNACLE J, CÔTÉ N, KRAPF L, et al. Chronic kidney disease and the pathophysiology of valvular heart disease[J]. Can J Cardiol, 2019, 35(9): 1195-1207. doi: 10.1016/j.cjca.2019.05.028
|
| [24] |
朱鹏程, 张倩, 卞金辉, 等. 二叶式主动脉瓣钙化关键基因的生物信息学分析[J]. 实用临床医药杂志, 2021, 25(9): 9-13, 17. doi: 10.7619/jcmp.20211339
|
| [25] |
KAJIMOTO K, SATO N, TAKANO T. Relationship of renal insufficiency and clinical features or comorbidities with clinical outcome in patients hospitalised for acute heart failure syndromes[J]. Eur Heart J, 2017, 6(8): 697-708.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: